Ecosystem
Beta Site
Search Results
11 items found for "Yifei Feng"
Posts (3)
- Dr. Juan José Fung - Dr. GPCR Podcast
Juan Jose Fung, Principal Scientist, at GPCR Therapeutics.
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong, 2016; Kuang, Feng
- Nanobodies: New Dimensions in GPCR Signaling Research
., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D. M., Thian, F.
Other Pages (8)
- Ep 58 with Dr. Juan José Fung
Juan José Fung About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Fung received his Ph.D. from the Stanford University School of Medicine under the mentorship of Dr. Fung continued his Postdoctoral training in Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr.
- Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma
Li , Zixu Gao , Shaoluan Zheng , Yiteng Ding , Jiani Ji , Chenlu Wei , Tianyi Zhang , Yu Zhu , Jia Feng , Feng Qin , Yanwen Yang , Chuanyuan Wei , Jianying Gu Tags G protein-coupled receptors , Immunotherapy
- AGPCR 24 Session II
Yuling Feng The ADGRF5/GPR116 receptor is a key regulator of lymphatic endothelial cell identity and Yuling Feng Abstract Only available for AGPCR 24 Workshop Attendees Authors & Affiliations "Shen,Tingzhen About Yuling Feng "I am currently a postdoctoral research fellow working with aGPCR pharmacology and Yuling Feng on the web LinkedIn The ADGRF5/GPR116 receptor is a key regulator of lymphatic endothelial
